De novo variants in TCF7L2 are associated with a syndromic neurodevelopmental disorder

TCF7L2 encodes transcription factor 7‐like 2 (OMIM 602228), a key mediator of the evolutionary conserved canonical Wnt signaling pathway. Although several large‐scale sequencing studies have implicated TCF7L2 in intellectual disability and autism, both the genetic mechanism and clinical phenotype have remained incompletely characterized. We present here a comprehensive genetic and phenotypic description of 11 individuals who have been identified to carry de novo variants in TCF7L2, both truncating and missense. Missense variation is clustered in or near a high mobility group box domain, involving this region in these variants' pathogenicity. All affected individuals present with developmental delays in childhood, but most ultimately achieved normal intelligence or had only mild intellectual disability. Myopia was present in approximately half of the individuals, and some individuals also possessed dysmorphic craniofacial features, orthopedic abnormalities, or neuropsychiatric comorbidities including autism and attention‐deficit/hyperactivity disorder (ADHD). We thus present an initial clinical and genotypic spectrum associated with variation in TCF7L2, which will be important in informing both medical management and future research.

[1]  Richard A Marini,et al.  Large-scale targeted sequencing identifies risk genes for neurodevelopmental disorders , 2020, Nature Communications.

[2]  Emily E. Burke,et al.  A myelin-related transcriptomic profile is shared by Pitt–Hopkins syndrome models and human autism spectrum disorder , 2020, Nature Neuroscience.

[3]  Emily E. Burke,et al.  A myelin-related transcriptomic profile is shared between Pitt Hopkins syndrome models and human autism spectrum disorder , 2019, Nature Neuroscience.

[4]  Matthew W. Mosconi,et al.  Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of Autism , 2019, Cell.

[5]  Avi Ma’ayan,et al.  Habenular Tcf7l2 links nicotine addiction to diabetes , 2019, Nature.

[6]  M. Gerstein,et al.  A Single-Cell Transcriptomic Atlas of Human Neocortical Development during Mid-gestation , 2019, Neuron.

[7]  Bradley P. Coe,et al.  Inherited and multiple de novo mutations in autism/developmental delay risk genes suggest a multifactorial model , 2018, Molecular Autism.

[8]  Jinyu Wu,et al.  Prioritized High-Confidence Risk Genes for Intellectual Disability Reveal Molecular Convergence During Brain Development , 2018, Front. Genet..

[9]  Z. Kozmík,et al.  Tcf7L2 is essential for neurogenesis in the developing mouse neocortex , 2018, Neural Development.

[10]  M. Daly,et al.  Regional missense constraint improves variant deleteriousness prediction , 2017, bioRxiv.

[11]  H. Clevers,et al.  Tcf7l2 plays crucial roles in forebrain development through regulation of thalamic and habenular neuron identity and connectivity. , 2017, Developmental biology.

[12]  J. Kuźnicki,et al.  TCF7L2 mediates the cellular and behavioral response to chronic lithium treatment in animal models , 2017, Neuropharmacology.

[13]  Deciphering Developmental Disorders Study,et al.  Prevalence and architecture of de novo mutations in developmental disorders , 2017, Nature.

[14]  L. Vissers,et al.  Meta-analysis of 2,104 trios provides support for 10 new genes for intellectual disability , 2016, Nature Neuroscience.

[15]  S. Goldman,et al.  Dual regulatory switch through interactions of Tcf7l2/Tcf4 with stage-specific partners propels oligodendroglial maturation , 2016, Nature Communications.

[16]  D. Valle,et al.  GeneMatcher: A Matching Tool for Connecting Investigators with an Interest in the Same Gene , 2015, Human mutation.

[17]  Orion J. Buske,et al.  The Matchmaker Exchange: A Platform for Rare Disease Gene Discovery , 2015, Human mutation.

[18]  Boris Yamrom,et al.  The contribution of de novo coding mutations to autism spectrum disorder , 2014, Nature.

[19]  Christopher S. Poultney,et al.  Synaptic, transcriptional, and chromatin genes disrupted in autism , 2014, Nature.

[20]  J. Kuźnicki,et al.  Postnatal isoform switch and protein localization of LEF1 and TCF7L2 transcription factors in cortical, thalamic, and mesencephalic regions of the adult mouse brain , 2012, Brain Structure and Function.

[21]  Doron Lancet,et al.  Association of the Type 2 Diabetes Mellitus Susceptibility Gene, TCF7L2, with Schizophrenia in an Arab-Israeli Family Sample , 2012, PloS one.

[22]  A. Hecht,et al.  Alternative splicing of Tcf7l2 transcripts generates protein variants with differential promoter-binding and transcriptional activation properties at Wnt/β-catenin targets , 2009, Nucleic acids research.

[23]  Laura J. Scott,et al.  Tissue-specific alternative splicing of TCF7L2 , 2009, Human molecular genetics.

[24]  Hans Clevers,et al.  HDAC1 and HDAC2 Regulate Oligodendrocyte Differentiation By Disrupting β-Catenin-TCF Interaction , 2009, Nature Neuroscience.

[25]  D. Altshuler,et al.  Tissue-specific alternative splicing of TCF 7 L 2 , 2009 .

[26]  J. Pankow,et al.  Variation in TCF7L2 and Increased Risk of Colon Cancer , 2008, Diabetes Care.

[27]  Hans Clevers,et al.  Wnt/β-Catenin Signaling in Development and Disease , 2006, Cell.

[28]  H. Stefánsson,et al.  Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes , 2006, Nature Genetics.

[29]  H Clevers,et al.  A gene family of HMG-box transcription factors with homology to TCF-1. , 1992, Nucleic acids research.